News

The application enables discovery of new pharmaceutical drugs to combine image data from multiple trials in a single database, eweek.com reported. Enterprise Core-Lab-in-a-Box helps in management of medical

The company will use the fund for preclinical and clinical development of its new class of bridged bicyclic antibiotics known as Bicyclolides which are said to act as

PA32540 is an investigational coordinated-delivery tablet of immediate-release omeprazole, a proton pump inhibitor (PPI), layered around pH-sensitive aspirin. During the trial, subjects with known cardiovascular disease and already

ST10 is an oral ferric iron-based pharmaceutical that can be administered to patients with improved tolerability compared to currently marketed oral iron treatments, the company said. The trial

Prolensa is a once-daily topical nonsteroidal anti-inflammatory (NSAID) compound which is used to treat ocular inflammation and pain following cataract surgery.. The two Phase 3 controlled, double-masked, multi-center,

Nexavar is an oral anti-cancer therapy for liver cancer and for the treatment of patients with advanced kidney cancer As per the deal, Bayer will have the final

The collaboration agreement is valued at €2.8m. As per the deal, BioFocus will provide expanded medicinal chemistry resource, biology services, and an option to perform ADME services for

The Phase III randomized, double-blind, placebo-controlled, parallel-design clinical study, assessed the safety and efficacy of Cialis 2.5 or 5 mg for once daily use in 606 sexually active

According to the deal, a new company Tasly-SemBioSys Pharmaceuticals will be set up in Tianjin, China, pharmabiz.com reported. The new project intends to develop and commercialize many products